Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deerac Fluidics was a life science instrumentation company specializing in high-precision, nanoliter-scale liquid handling systems. Founded as a spin-out from Trinity College Dublin, the company developed the Equator and Latitude series of automated dispensers, which utilized proprietary valve-based technology for low-volume dispensing. These systems were widely used in genomics, proteomics, and high-throughput screening to reduce reagent costs and improve assay performance. In 2008, the company was acquired by Labcyte, integrating its technology into a broader portfolio of acoustic and non-contact liquid handling solutions. The technology remains a significant component of laboratory automation workflows for drug discovery and genomic research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deerac Fluidics.